Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212335 | SCV000150066 | uncertain significance | not provided | 2024-04-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26689913, 21127055, 20159562, 35534704) |
Ambry Genetics | RCV000116157 | SCV000172959 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-05-04 | criteria provided, single submitter | clinical testing | The p.D1138Y variant (also known as c.3412G>T), located in coding exon 19 of the BRIP1 gene, results from a G to T substitution at nucleotide position 3412. The aspartic acid at codon 1138 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV003460838 | SCV004214768 | uncertain significance | Familial cancer of breast | 2023-09-05 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV004698825 | SCV005200765 | uncertain significance | Hereditary cancer | 2024-08-12 | criteria provided, single submitter | clinical testing |